Thought it would be a good idea to share more details on the significance of the news and the upcoming Taiwan FDA clearance in March 2020 quarter. About Holly Stone Healthcare Co Ltd Holy Stone Healthcare Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and wholesale of medical equipment. The Company's main products include latent tuberculosis infection test reagents, Ostenil branded joint cavity injection and other medical equipment. The Company is also involved in the manufacture of western medicines, as well as the research and development of new drugs and new medical materials. The Company distributes its products in domestic market and to overseas markets. Holly Stone Healthcare is listed on Taipei Stock Exchange with a share price of $10 TWD and a market cap of $1.2 billion TWD ( AUD 58 million). Reference: https://www.reuters.com/companies/4194.TWO/profile Prevalence of ASD in Taiwan About 1 in 59 children has been identified with autism spectrum disorder (ASD) according to estimates from CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network. The number of identified persons with ASD in Taiwan was 13,366 in 2013. IMO unfortunately number of ASD in Taiwan in 2019 would be over 20,000. Reference: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0109567
IMO this is a multibagger stock. Good luck to all and remember always do your own research. My sentiments keep buying.
